glp-1 and bowel obstruction Gut Side Effects: Bloating & Constipation Tips Monitoring Patients Who Take GLP-1

**Average less bloating based on a placebo-controlled, crossover clinical study of 19 participants who took identical test meals, once with Flatter Me and once with a placebo

CANVAS demonstrated a 14% reduction in MACE in patients with T2DM and a high cardiovascular risk ( 4.1.2 Cardiovascular results in studies aimed at CVD The CREDENCE clinical trial evaluated the effects of canagliflozin (100 mg daily) versus placebo in 4,401 patients with T2DM and CKD

On the US findings, Wooton said most employers do not cover GLP-1 drugs for weight loss

The compounded GLP-1 regulatory landscape has changed materially since early 2025, and only the company and relevant regulatory bodies can speak to current compliance status

93,94 These dual mechanisms of K ATP channel modulation underlie the ability of GLP-1 to act as a -cell glucose sensitizer so that it may facilitate glucose metabolism-dependent depolarization of -cells